Conflicts of interest L.W., L.A., S.T.B., T.K., N.R.K., E.N., L.N., T.M.P.R., D.B.S
Gastrointestinal adverse events, including nausea, constipation, diarrhea, and vomiting, are the most commonly reported side effects
Semaglutide typically begins at 0.25mg, whereas tirzepatide begins at 5mgthis difference reflects pharmacological potency, not a safety concern
Anticholinergic medications, which commonly cause dry mouth, might delay tablet disintegration and affect the absorption profile of both active ingredients
Central nervous system applications are an active and rapidly growing area
Mater Today 43:166184